跳至主要内容
临床试验/CTRI/2025/06/089282
CTRI/2025/06/089282尚未招募2 期

A comparative study on the efficacy of Ayurveda and Homeopathy in treating Autism Spectrum Disorder: An evidence-based approach.

Parul University1 个研究点 分布在 1 个国家入组 90 人开始时间: 2026年10月6日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
入组人数
90
试验地点
1
主要终点
1 Improvement in ISAA score

研究概览

简要总结

ASD is Neurobehavior disease affecting the social behaviour and learning skill of child.

Background & Rationale:

 Autism Spectrum Disorder (ASD) in children is aneurodevelopmental condition marked by challenges in communication, behavior,and sensory integration. Conventional treatments are often limited tobehavioral therapies and symptomatic pharmacological interventions, withvarying efficacy and potential side effects. Integrative medicalapproaches—particularly Ayurveda and Homeopathy—offer promising adjunctsthrough individualized, holistic care.

 Ayurveda Perspective:

 Ayurveda conceptualizes ASD in terms of Unmada orVata-predominant neurodevelopmental imbalances, often linked to disturbances inAgni (digestive fire), Ojas (vital essence), and the nervous system (MajjaDhatu). Ayurvedic treatment protocols focus on restoring systemic equilibriumusing medhya rasayana (nootropic herbs), dietary corrections, and Panchakarmaprocedures, thereby aiming to improve cognitive function, social behavior, andphysiological balance in children with ASD.

 Homeopathy Perspective:

 Homeopathy, based on the principle of individualized remedyselection, has been observed to modulate behavioral and emotional dysregulationin ASD. It addresses the child’s unique symptom profile—emotional, physical,and developmental—to stimulate the body’s innate healing response. This alignswith non-invasive, child-friendly modalities that are crucial in pediatriccare.

 Objective:

 This trial aims to evaluate the clinical efficacy and safetyof Ayurveda and Homeopathy interventions in the management of pediatric ASDsymptoms. It explores the potential synergistic benefits of integrative,personalized treatments in enhancing quality of life and developmentaloutcomes.

研究设计

研究类型
干预性
分配方式
随机
随机化方法
Computer generated randomization
盲法
开放(无盲法)

入排标准

年龄范围
3.00 Year(s) 至 16.00 Year(s)(—)
性别
All

入选标准

  • 1 Children with Diagnosed cases of ASD 2 Children with ASD with parents consent to willing to participate in clinical trial 3 Children with score more than 100 on ISAA (Indian Scale for Autism Assessment).

排除标准

  • 1 Children age less than 3 years and above 16 years 2 Children with ASD and their parents not willing to participate or giving consent 3 Children with score less than 100 on ISAA (Indian Scale for Autism Assessment) 4 Child with ASD with other neurobehavior diseases, epilepsy and progressive neurological disorders.

结局指标

主要结局

1 Improvement in ISAA score

时间窗: at the time of enrollment | 30 days | 60 days | 90 days | 120 days

2 Improvement in Cognition and concentration

时间窗: at the time of enrollment | 30 days | 60 days | 90 days | 120 days

次要结局

  • 1 Improvement in social communication(2 Improvement in speech)

研究者

申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

标识符

CTRI 编号
CTRI/2025/06/089282

日期

最近更新
(去年)

监管与共享

个体参与者数据共享计划
否

Will individual participant data (IPD) be shared publicly (including data dictionaries)?   Response  - NO

相似试验